Intellectual Property & Patent Reform | Association for Accessible Medicines
COVID-19 and AAM - FAQ's and resources from the U.S. generics and biosimilars industry.

Intellectual Property & Patent Reform


Please see below for shareable resources, press releases and other content relating to this issue. You can also use the search bar in the header of our website to search for specific keywords across all content on the site.

PDFJul 24, 2017Erica Klinger
Rx Solutions Fact Sheet - Patent/IPR
Download |
PDFMay 23, 2019Tony Kurilla
Fact Sheet: Patent Settlements DO Help Patients
Download |
Press Release Feb 13, 2019 Rachel Schwartz
AAM Welcomes Re-Introduction of the PACED Act
Press Release Oct 17, 2018 Rachel Schwartz
AAM Files Amicus Brief in Helsinn v Teva
Press Release May 18, 2018 Jeff Francer
AAM Files Brief to Oppose Pharmaceutical Company Abuse of the Patent System

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.